Central Clinical Hospital of Presidential Administration of Russian Federation Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2007
NCT00997750
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Department of Cardiology, Central Clinical Hospital of Presidential Administration of Russian Federation

Active Ingredients

Drugs in Phase 4 Trials (1)

lornoxicam (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1